1st Quarter - Report

CHAMBER HILL STRATEGIES for GLAXOSMITHKLINE, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program; and broad payment reform bills S.1871, H.R.2810, S.2000, H.R.4015, S.2110, S.2157, and H.R.4302.

LobbyistCovered position, as disclosed
JENNIFER BELL Health Policy Advisor, Sen. Finance Committee
MICHAELA SIMS Legislative Counsel, Sen. Bob Kerrey

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2000 (113th), H.R. 4015 (113th), S. 1871 (113th), H.R. 4302 (113th), H.R. 2810 (113th), S. 2157 (113th), S. 2110 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.